RecruitingNCT04098146

Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis

Studying Osteonecrosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AO Innovation Translation Center
Principal Investigator: Rüdiger Zimmerer, PD, MD
University of Leipzig
Intervention: Surgical Resection and Reconstruction(procedure)
Enrollment: 300 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2030

Study locations (19)

University of Florida College of Medicine, Jacksonville, Florida, United States
University of Illinois Chicago, Chicago, Illinois, United States
Northwell Health Cancer Institute, New Hyde Park, New York, United States
Mount Sinai Hospital, New York, New York, United States
John Peter Smith Health Network, Fort Worth, Texas, United States
Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg, Germany
University Hospital RWTH Aachen, Aachen, Germany
University Hospital Charité, Berlin, Germany
Hannover Medical School, Hanover, Germany
Universitätsklinikum Heidelberg, Heidelberg, Germany
University Hospital Leipzig, Leipzig, Germany
Klinikum der LMU München, Munich, Germany
University Hospital Ulm, Ulm, Germany
Shimane University, Izumo, Japan
Erasmus University Medical Centre, Rotterdam, Netherlands
+4 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04098146 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis →

← Back to all trials